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Background: This study aimed to assess differences in Quality of Life (QoL) across eating disorder (ED) diagnoses,
and to examine the relationship of QoL to specific clinical features.
Results: 199 patients with a diagnosed ED completed the Clinical Impairment Assessment (CIA) [Cognitive Behavior
Therapy and Eating Disorders, 315–318, 2008] and the Eating Disorders Examination (EDE) [Int J Eat Disord 6:1–8].
Differences between diagnostic groups were examined, as were differences between restrictive and binge-purge
subtypes.
CIA scores and EDE scores were positively correlated and higher in groups with binge-purge behaviours. CIA scores
were not correlated with BMI, illness duration or frequency of bingeing/purging behaviours, except in the binge-purge
AN group, where CIA scores negatively correlated with BMI.
Conclusions: Patients with EDs have poor QoL and impairment increases with illness severity. Patients with binge/
purge diagnoses are particularly impaired. It remains unclear which clinical features best predict the degree of
impairment experienced by patients with EDs.
Keywords: Eating disorders, Anorexia nervosa, Bulimia nervosa, Clinical impairment assessment, Functional impairment,
Quality of lifeBackground
In recent years, the assessment of Quality of Life (QoL)
in people with eating disorders (EDs) has been subject
to considerable research interest. The World Health
Organisation defines QoL as ‘an individual’s perception
of their position in life in the context of the culture and
value system in which they live and in relation to their
goals, expectations, standards and concerns’ [1]; page
145. It is a multidimensional construct that is under-
stood to include perceptions about various areas of life,
including physical, psychological, social and emotional
domains [1]. QoL measures are beginning to be recog-
nized as a key patient-oriented measure of outcome [2].
To date, studies in EDs have indicated significantly
reduced QoL in this patient group, to a degree that is
comparable with QoL findings in various other serious* Correspondence: ulrike.schmidt@kcl.ac.uk
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reproduction in any medium, provided the orillnesses and disorders, such as angina and anxiety disor-
ders [3,4]. Individuals with EDs seem to be particularly
impaired in psychological and social domains [5,6].
Patterns of diagnostic differences are inconsistent across
studies, with some studies finding no significant differ-
ences between diagnostic groups [7,8], some reporting
lower QoL in individuals with anorexia nervosa (AN) than
bulimia nervosa (BN) [9-11], and others reporting higher
QoL in AN [12,13]. However, studies that report higher
QoL in AN also report seemingly contradictory findings,
such as an increased presence of suicidal thoughts
and self-harming behaviours in this group [12]. It is also
notable that studies finding less impairment in AN have
tended to use generic, rather than ED specific measures of
QoL, which - as has been hypothesized - may be less
sensitive to certain aspects of impairment associated with
these disorders [14]. Inconsistencies in the differences
reported across diagnostic groups may also be attributable
to the presence of diagnostic subtypes. There is some evi-
dence that individuals with bingeing and/or purging forms
of AN are more impaired than individuals with restrictivel Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.jeatdisord.com/content/1/1/43AN [8,15]. Several authors have suggested that a lack of
insight into the negative impact of restrictive AN may
inflate self-reported measures of QoL in this group –
restrictive EDs are often experienced as ego-syntonic due
to the valued weight loss associated with these disorders
[13,16].
It remains unclear how specific symptoms and behav-
iours associated with EDs impact on QoL. There is evi-
dence that the presence of both bingeing [9,17-19] and
purging behaviours [14,20,21] negatively affect QoL in
both clinical and community samples, but evidence re-
garding the impact of the frequency of these behaviours
is sparse and contradictory [6,19,22,23]. The effect of
BMI on QoL is relatively unexplored, particularly in
underweight ED samples [6], though there is some evi-
dence that QoL falls with decreased BMI [11]. There is
similarly little evidence on the relationship between illness
chronicity and QoL, though one study has found lower
QoL in individuals with illness duration greater than five
years compared to those ill for less than five years [24].
The present study used the Clinical Impairment As-
sessment (CIA) [25,26], a measure of QoL specifically
designed for use in ED populations. The CIA is designed
to assess the perceived effects of having an ED on vari-
ous domains, including social, emotional and cognitive
aspects. Relevant domains were identified by clinicians
and through interviews with patients diagnosed with an
ED. The authors decided not to include items about pos-
sible physical effects of having an ED (e.g. feeling faint
or cold, palpitations), arguing that individuals with EDs
may not necessarily associate these effects with their
eating behaviours. The CIA specifically assesses impair-
ment that occurs as a result of an ED, whether stemming
from eating behaviours or associated concerns about body
shape. CIA scores have been shown to correlate closely
with clinician ratings of psychosocial impairment, suggest-
ing that the measure accurately captures clinically relevant
information [26]. CIA scores have also been shown to cor-
relate with ED symptom severity [26], as measured by the
Eating Disorder Examination Questionnaire (EDE-Q) [27].
This supports the authors’ assertion that the CIA specific-
ally measures impairment that is perceived as secondary
to (that is it results from) an individual’s ED.
The aims of the current study were to extend previous
findings with the CIA, using a large ED sample com-
posed of a mixture of diagnoses. In particular, the study
sought to increase the available data on CIA scores in
individuals with AN –previous work with this measure
has included only small numbers of participants with
this diagnosis [26,28] – and to consider possible differ-
ences between restrictive and binge-purge subtypes. In
addition, the study aimed to examine the relationships
between CIA score and clinical features including Eating
Disorder Examination scores [29], BMI, illness durationand diagnosis. We hypothesised that individuals with a
diagnosis of AN would report more impairment on the
CIA than individuals with BN or EDNOS, as previous
findings indicate that people with AN often report more
impairment than other groups when ED-specific mea-
sures of QoL are used [11,30]. We expected to replicate
findings [26] of a positive correlation between CIA
scores and ED severity, as measured by the EDE. We
also hypothesised that CIA scores would be higher in
patients with a longer duration of illness, in patients
with lower BMIs and in patients with more frequent
bingeing and purging behaviours.
Methods
Participants
Participants were all treatment-seeking individuals who
were assessed at an outpatient ED service and recruited
to take part in three clinical trials of outpatient treat-
ments for anorexia and bulimia nervosa, recruiting from
catchment area based specialist ED services and with
minimal exclusion criteria [31-33]. The data reported
here were collected at baseline, as part of a larger as-
sessment battery used prior to randomising participants
to a treatment condition. Participants were primarily
recruited from the outpatient ED service of the South
London and Maudsley NHS Foundation Trust. A small
number of participants (N = 4) were recruited from
other sites within London. Ethical approval for each
trial was granted by a local NHS Research Ethics
Committee.
Exclusion criteria were insufficient literacy or English
language to complete research assessments, presence of
serious physical or psychiatric co-morbidity requiring
treatment in its own right (e.g. substance dependence,
psychosis, diabetes), history of head injury or current
pregnancy. Participants taking antidepressant medica-
tions were included, provided their dose had remained
stable over the preceding four weeks.
The final sample reported here included 199 patients
(N = 189 female) with a DSM-IV-TR [34] diagnosis of
either AN (N = 84), BN (N = 49) or EDNOS (N = 66).
Diagnoses were established by experienced ED clini-
cians during an initial clinical assessment. Due to the
heterogeneity of AN and EDNOS as diagnoses, patients
in these groups were also classified as having a res-
trictive presentation or a binge-purge presentation, as
defined in [31-33]. The AN group was composed of 42
restrictive and 42 binge-purge cases; the EDNOS group
was composed of 28 restrictive and 38 binge-purge
cases.
A power calculation revealed that at a total sample size
of 199 across the 5 groups, distributed across the groups
as specified, a one-way analysis of variance will have 90%
power to detect at the 0.01 level an effect size of 0.11.
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Diagnosis and duration of illness were established during
an initial clinical assessment. The measures described
below were then administered by a researcher, as part of a
larger battery of measures associated with one of the
clinical trials. Height and weight were also measured dur-
ing this assessment and used to calculate BMI (kg/m2).Clinical impairment assessment (CIA)
The CIA (25,26) is a 16-item measure of functional im-
pairment designed for use in individuals with EDs. It be-
gins with the stem question: “Over the past 28 days, to
what extent have your eating habits, exercising or feel-
ings about your eating, shape and weight…?”. This ques-
tion is followed by 16 items enquiring about different
types of impairment (e.g. “… made it difficult to concen-
trate?”; “…made it difficult to eat out with others?”).
Each item is rated on a 4-point scale from ‘not at all’
(scored as 0) to ‘a lot’ (scored as 3). Some items are
marked ‘if applicable’ and can be left blank if not rele-
vant for the participant.
The CIA is scored by adding all items to give a total
score. Any missing items are pro-rated and added to this
total, provided that at least 12 of the 16 items have been
rated. The CIA therefore generates a single global score,
with higher values indicating greater functional impair-
ment. The maximum possible score is 48. The CIA has
been shown to have satisfactory internal consistency,
test-retest reliability, construct and discriminant validity
and also sensitivity to change [25].Eating disorder examination (EDE)
The EDE (29) is a semi-structured interview designed to
assess key behaviours and cognitions associated with ED
psychopathology. In common with the CIA, it focuses
on the preceding 28 days. Each item of the interview is
numerically scored and then used to generate four sub-
scale scores (dietary restraint, eating concern, weight
concern and shape concern). The mean of these subscale
scores can also be used as a global measure of ED psy-
chopathology. The range of possible scores in each case
is 0 to 6, with higher scores indicating greater severity.
The EDE also gathers information on key ED behav-
iours over the preceding 28 days, including the number
of objective binge episodes (OBEs), number of subjective
binge episodes (SBEs) and number of episodes of self-
induced vomiting. OBEs are defined as episodes in
which the quantity of food eaten is objectively large and
the individual experiences a loss of control while eating.
In contrast, SBEs are defined as episodes in which the
individual experiences a loss of control and views the
amount eaten as excessive, but the amount eaten is not
objectively large.The EDE is a reliable and widely used assessment of
ED symptomatology with good discriminant validity and
satisfactory internal reliability [35].Analysis
All demographic and clinical variables were non-
normally distributed and attempts to transform these
variables were unsuccessful. Non-parametric analyses
were therefore used and group differences examined
using Kruskall Wallis tests, followed by post-hoc Mann
Whitney U tests.
The distribution of the CIA scores was also non-
normal. Outliers were defined as values lying more than
2.5 standard deviations from the mean, and were re-
moved from further analyses (N = 4). CIA scores
remained non-normally distributed and attempts to
transform the scores were unsuccessful. Non-parametric
analyses were therefore used to examine group differ-
ences in CIA scores. Kruskall Wallis tests were con-
ducted, followed by post-hoc Mann Whitney U tests.
Effect sizes were calculated using the formula r = Z/√N,
then converted to Cohen’s d scores. Effect sizes are
defined as small (d < 0.4), medium (0.4 ≤ d < 0.8) or
large (d ≥ 0.8).
The AN and EDNOS groups were then divided into re-
strictive (R) and binge-purge (BP) subgroups, creating a
total of five diagnostic groups (AN-R, AN-BP, EDNOS-R,
EDNOS-BP, BN). Differences in demographic and clinical
variables were examined using Kruskall Wallis tests and
post-hoc Mann Whitney U tests. Differences in CIA
scores across these groups were examined in the same
way, and effect sizes calculated as described above.
Correlations between CIA scores and clinical variables
were examined using Spearman’s rank correlation ana-
lyses. Analyses were conducted for the sample as a
whole, and also separately for each diagnostic group and
subgroup. In all cases a significance level of α = .05 was
used.Results
Demographic and clinical characteristics: AN, BN, EDNOS
As Table 1 shows, the three diagnostic groups did not
differ in age, duration of illness, global EDE score, eating
concern subscale scores or weight concern subscale
scores. Group differences in BMI were as expected –
BMI was lowest in the AN group, highest in the BN
group and intermediate in the EDNOS group. The AN
group also reported higher dietary restraint and lower
shape concern than the BN and EDNOS groups, who
did not differ from one another. The BN group reported
more OBEs and more episodes of self-induced vomiting
than the AN and EDNOS groups, who did not differ
from one another. The BN group also reported more
Table 1 Demographic and clinical characteristics: AN, BN, EDNOS
Median (IQR)
AN (n = 84) BN (n = 49) EDNOS (n = 66) Kruskall Wallis statistic Post-hoc tests
Age (yrs) 24.50 (10.0) 28.00 (9.00) 26.50 (10.25) n.s.
Duration of illness (yrs) 7.00 (8.50) 9.00 (10.25) 9.00 (9.00) n.s.
BMI 16.30 (1.78) 22.00 (6.34) 18.40 (5.45) H = 100.97 p < .001 AN < EDNOS < BN
EDE global score 3.40 (1.83) 3.79 (1.06) 3.62 (2.14) n.s.
EDE dietary restraint 3.90 (2.05) 3.60 (1.87) 3.20 (2.75) H = 9.13 p = .010 AN > BN = EDNOS
EDE eating concern 2.90 (2.00) 3.00 (2.20) 2.70 (2.35) n.s.
EDE weight concern 3.25 (2.35) 4.43 (1.94) 4.35 (2.60) n.s.
EDE shape concern 3.60 (2.15) 5.07 (1.32) 4.48 (2.58) H = 23.06 p < .001 AN < EDNOS = BN
OBE 0.00 (4.50) 16.00 (22.50) 0.00 (9.75) H = 46.66 p < .001 AN = EDNOS < BN
SBE 0.00 (7.00) 6.00 (19.00) 1.00 (16.00) H = 6.78 p = .034 AN < BN
Self induced vomiting 0.00 (12.25) 15.00 (23.50) 0.00 (11.50) H = 24.917 p < .001 AN = EDNOS < BN
Notes: AN, anorexia nervosa, BN, bulimia nervosa, EDNOS, eating disorder not-otherwise-specified, BMI, Body Mass Index, EDE, Eating Disorder Examination, OBE,
Objective Binge Episodes, SBE, Subjective Binge Episodes.
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significantly different from AN or BN.
The groups were therefore broadly similar in terms of
age, illness duration and illness severity, with some dif-
ferences in specific features that seemed consistent with
the diagnostic profile of each group.CIA scores: AN, BN, EDNOS
There was no significant difference between the AN, BN and
EDNOS groups in CIA scores [H(2) = 3.96, p = .138]. The












Age 23.0 (10.5) 26.0 (12.0) 25.0 (9.0) 27.0 (8.0) 28.0
Duration of illness 7.0 (7.13) 6.0 (8.0) 7.0 (12.0) 9.0 (9.25) 9.0 (
BMI 16.0 (2.33) 17.2 (2.2) 16.8 (1.65) 22.4 (6.47) 22.0
EDE global score 2.95 (1.85) 2.7 (2.5) 3.9 (1.75) 4.06 (1.49) 3.79
EDE dietary
restraint
3.65 (2.35) 3.2 (3.4) 4.4 (1.7) 3.0 (2.6) 3.6 (
EDE eating
concern
2.4 (2.75) 1.6 (4.0) 3.3 (2.0) 3.2 (1.7) 3.0 (
EDE weight
concern
3.2 (2.65) 3.5 (3.38) 3.35 (2.5) 4.6 (1.43) 4.43
EDE shape
concern
3.6 (2.48) 2.8 (3.1) 3.85 (2.1) 5.07 (1.22) 5.07
OBE 0.0 (0.0) 0.0 (0.0) 3.0 (20.0) 5.0 (27.0) 16.0
SBE 0.0 (2.0) 0.0 (1.0) 2.0 (14.5) 8.0 (23.5) 6.0 (
Self induced
vomiting
0.0 (0.0) 0.0 (0.0) 9.0 (28.0) 6.0 (18.0) 15.0
Notes: AN, anorexia nervosa, BN, bulimia nervosa, EDNOS, eating disorder not-other
Disorder Examination, OBE, Objective Binge Episodes, SBE, Subjective Binge EpisodeIQR = 13.1; BN median = 34.13, IQR = 8.23; EDNOS
median = 31.0, IQR = 13.68.
Demographic and clinical characteristics: restrictive and
binge-purge subtypes
As Table 2 shows, the five diagnostic subgroups did not
differ in age or duration of illness, but did differ in BMI,
EDE global and subscale scores and frequency of ED be-
haviours. In the case of BMI, the AN-R group had the
lowest BMIs, the AN-BP and EDNOS-R groups had
intermediate BMIs, and the EDNOS-BP and BN groups
had the highest BMIs. In general, individuals with binge-nd binge-purge subtypes
49)
Kruskall Wallis Post hoc
(9.0) n.s.
10.25) n.s.
(6.34) H = 127.08, p < .001 ANR < ANBP = EDNOSR < BN = EDNOSBP
(1.06) H = 18.03, p = .001 EDNOSR = ANR < BN = ANBP = EDNOSBP
1.87) H = 16.18, p = .003 EDNOSBP = EDNOSR = BN = ANR < ANBP
2.2) H = 16.52, p = .002 EDNOSR = ANR < BN = EDNOSBP = ANBP
(1.94) H = 16.87, p = .002 ANR = ANBP = EDNOSR < BN = EDNOSBP
(1.32) H = 47.39, p < .001 EDNOSR = ANR = ANBP < EDNOSBP = BN
(22.5) H = 93.74 p < .001 ANR = EDNOSR < ANBP = EDNOSBP < BN
19.0) H = 24.91 p < .001 ANR = EDNOSR < ANBP = BN = EDNOSBP
(23.5) H = 70.26 p < .001 ANR = EDNOSR < EDNOSBP
< BN EDNOSBP = ANBP = BN
wise-specified, R, restrictive, BP, binge-purge, BMI, Body Mass Index, EDE, Eating
s.
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had higher EDE scores than individuals with restrictive
EDs and more frequently engaged in bingeing and pur-
ging behaviours. A somewhat different pattern emerged
for the dietary restraint subscale of the EDE, for which
the AN-BP group scored higher than all other groups,
who did not differ from one another. Group differences
therefore were broadly in line with the diagnostic profile
of each group, and suggest a somewhat greater illness
severity in the binge-purge spectrum groups.CIA scores: restrictive and binge-purge subtypes
There was a significant difference in CIA scores across
the diagnostic subgroups [H(4) = 9.49, p = .05] (for
medians and IQRs see Table 3). Post-hoc tests indicated
that the AN-BP group had higher CIA scores than both
the AN-R [U = 628.0, p = .049, d = 0.45] and EDNOS-R
[U = 362.5, p = .012, d = 0.64] groups, who did not differ
from one another. The BN group also had higher CIA
scores than the EDNOS-R group [U = 464.0, p = .032,
d = 0.51]. All group differences were of medium effect size.Correlations between clinical variables and CIA scores
Whole sample
CIA scores were correlated with the EDE global score
[r = .44, p < .001], and with all EDE subscale scores –
dietary restraint [r = .27, p < .001], eating concern [r = .48,
p < .001], weight concern [r = .39, p < .001], and shape
concern [r = .33, p < .001]. CIA scores were not correlated
with duration of illness, BMI, objective or subjective binge
frequency, or frequency of self-induced vomiting.Diagnostic groups
In the AN and BN groups, CIA scores were positively
correlated with EDE global score and all subscales ex-
cept dietary restraint. In the EDNOS group, CIA scores
were positively correlated with EDE global score and all
subscale scores (see Table 4). CIA scores were not corre-
lated with duration of illness, BMI or frequency of
binge-purge behaviours in any of the diagnostic groups.Table 3 Median CIA scores for restrictive and binge-purge
subtypes
Diagnostic subtype n Median CIA score (IQR)
AN-R 42 31.0 (11.0)
EDNOS-R 28 28.0 (17.27)
AN-BP 42 36.5 (15.58)
EDNOS-BP 38 32.0 (12.73)
BN 49 34.1 (8.23)
Notes: AN, anorexia nervosa, BN, bulimia nervosa, EDNOS, eating disorder
not-otherwise-specified, R, restrictive, BP, binge-purge, CIA, Clinical Impairment
Assessment Questionnaire.Restrictive/binge-purge subgroups
Across the five diagnostic subgroups, CIA scores were
positively correlated with EDE global scores, and with
many of the subscale scores (see Table 4). In the AN-R,
EDNOS-R, EDNOS-BP and BN groups, there were no
correlations with any other clinical variables. However,
in the AN-BP group there was a negative correlation be-
tween CIA score and BMI [r = −.43, p = .005] and a
near-significant correlation between CIA score and ob-
jective binge frequency [r = −.30, p = .054].
Discussion
In the present sample, all ED groups had very elevated
CIA scores compared to previously reported population
norms: Young adult women in Sweden: M = 8.3, SD =
9.4 [28], adolescent Fijian girls: M = 11.6, SD = 10.9)
[36], young adult female Norwegian University students;
M = 6.4, SD = 7.5 [37]. There were no differences
in CIA scores between diagnostic groups (AN, BN,
EDNOS). However, when the groups were divided into
restrictive and binge-purge subtypes, significant differ-
ences were found. The AN-BP group had higher CIA
scores than the AN-R and EDNOS-R groups. The BN
group also had higher CIA scores than the EDNOS-R
group. This suggests a greater degree of functional
impairment in binge-purge spectrum diagnoses, and par-
ticularly in binge-purge type AN. This finding is consist-
ent with the fact that the binge-purge spectrum groups
also seemed to have a higher degree of clinical severity
than restrictive groups, as measured by the EDE global
and subscale scores. The exception to this pattern was
the EDE dietary restraint subscale, which was elevated in
the AN-BP group alone, relative to all other diagnostic
groups. Highly restrictive eating patterns therefore seem
to particularly characterise individuals with an AN-BP
diagnosis, which may account for their ability to main-
tain a low BMI (that is BMI < 17.5) despite engaging in
episodes of binge eating.
In all diagnostic groups, CIA scores were positively
correlated with EDE global scores and subscale scores.
The prominent contribution of attitudinal disturbances
to poor QoL in ED has recently also been highlighted by
Latner and colleagues [38] in a mixed ED outpatient
sample.
However, CIA scores were not correlated with other
clinical variables such as BMI, illness duration or fre-
quency of bingeing and/or purging behaviours. The
exception to this pattern was the AN-BP group, for
whom the CIA score was negatively correlated with BMI
and with frequency of OBEs, that is for individuals with
an AN-BP diagnosis, a higher BMI and more frequent
OBEs were associated with reduced impairment. This sug-
gests that, for people with AN-BP, a higher BMI acts as a
protective factor, reducing the functional impairment
Table 4 Correlations between CIA and EDE scores
Correlation with CIA score
EDE global EDE dietary restraint EDE eating concern EDE weight concern EDE shape concern
Diagnostic group AN .407** .213 .403** .435** .306**
BN .456** .071 .514** .493** .384**
EDNOS .479** .419** .516** .361** .427**
Diagnostic subtype AN-R .429** .187 .276 .500** .475**
EDNOS-R .571** .464* .547** .396* .539**
AN-BP .321* .138 .396** .366* .164
EDNOS-BP .436** .417* .514** .284 .317
BN .456** .071 .514** .493** .384**
Notes: **p < .01, *p < .05, AN, anorexia nervosa, BN, bulimia nervosa, EDNOS, eating disorder not-otherwise-specified, R, restrictive, BP, binge-purge, CIA, Clinical
Impairment Assessment Questionnaire, EDE, Eating Disorder Examination.
DeJong et al. Journal of Eating Disorders 2013, 1:43 Page 6 of 8
http://www.jeatdisord.com/content/1/1/43associated with this diagnosis. It is possible that a com-
bined effect of binge-purge behaviours and low BMI
accounts for the particularly poor QoL in this group. The
relationship between CIA scores and OBE frequency is
surprising, given that binge eating is typically experienced
by patients as highly distressing and causing significant
impairment. One possibility is that calorie consumption
during episodes of binge eating helps to mitigate the nega-
tive effects of extreme dietary restriction in this group.
This finding was however only a statistical trend and
requires further exploration to establish whether it can be
reliably replicated.
In terms of prognosis and need for treatment, AN is
considered to be the most severe ED. The finding that
individuals with restrictive EDs, including AN, report
less impairment and lower illness severity than other
groups seems inconsistent with this view. One possibility
is that the EDE and CIA are less sensitive to the symp-
toms and impairment associated with restrictive EDs.
There is some evidence that the EDE is insufficiently
sensitive and fails to detect all cases of AN and EDNOS
[35], especially for adolescent samples [39]. Previous
work also suggests that EDE global scores are somewhat
lower in AN than BN patient groups (MAN = 2.65,
MBN = 3.07) [31]. The ego-syntonic nature of these dis-
orders may also play a role here; individuals who view
their disorder as beneficial or rewarding are likely to re-
port fewer distressing symptoms and less associated im-
pairment [13]. This may be the case for people with
restrictive diagnoses, where the resulting weight loss is
highly valued and ego-dystonic aspects of the illness
may be less apparent. Bingeing and purging behaviours
tend to be viewed as highly distressing and therefore in-
dividuals with these behaviours may be more aware of
the negative impact of their ED. Alternatively, diagnostic
differences in treatment seeking behaviour and access to
specialist services could account for the lower severity
and impairment reported by restrictive patients in this
sample.Clinical understanding suggests that chronic illnesses
become more burdensome over time. It is therefore sur-
prising that illness duration was not related to level of
impairment in the present study. However, previous
research suggests that people with chronic illnesses are
motivated to adapt to their symptoms and this creates a
complex relationship between illness chronicity and QoL
[40]. It is hypothesized that chronic illness produces a
change in values and expectations that allows the indi-
vidual to adapt to the functional impairment associated
with his/her disorder – a change known as response
shift [41-43]. Response shift could account for the lack
of association found between illness chronicity and QoL
in this and other studies [11]. It has also been suggested
that any relationship between illness chronicity and QoL
in EDs may be obscured by fluctuations in symptom
severity over time, given the remitting/relapsing nature
of many EDs [18].
Limitations
A limitation of the current study is the use of a
treatment-seeking sample. Many individuals with EDs
do not seek treatment from specialist services [44-47]
and so findings in this sample may not generalise to
other groups, such as community samples of people with
EDs. Bohn and colleagues [26] note that it is often psy-
chosocial impairment that leads people with EDs to seek
help and so we might expect that a treatment-seeking
sample will be particularly impaired.
A second limitation is the lack of a measure of comor-
bid anxiety and depression. High levels of anxiety and
depression are common in people with EDs [48] and are
likely to cause significant impairment. The CIA’s focus
on impairment that is specifically related to ED thoughts
and behaviours may limit the impact of anxiety and/or
depression on our findings, but we are not able to
exclude the possibility that comorbid anxiety and depres-
sion significantly affect CIA scores. One previous study in
a community sample found a positive correlation between
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sion was not as strong a predictor of CIA score as were
EDE-Q scores [36]. This suggests that general distress, in-
cluding depression and anxiety, may affect CIA responses –
this is something that should be explored in future stud-
ies by including measures of comorbid anxiety and
depression. Finally, duration of illness was determined
by the clinical assessment (rather than by research
interview).
Implications for future research
The present study suggests that there are differences in
the degree of impairment across diagnostic groups and
in particular, important differences between binge-purge
and restrictive subtypes. This highlights the importance
of accurately characterising ED samples and differentiat-
ing these subtypes in future QoL research. It remains
unclear why individuals with restrictive EDs appear to
have less severe symptoms and less associated impair-
ment than those with binge-purge EDs. Research using a
range of QoL measures could help examine the possibil-
ity that this effect is due to insensitivity of the CIA and
EDE to detect disorder severity and impairment in this
group. Self-report measures could also be supplemented
with other indices of impairment (e.g. clinician ratings,
reports from close others), in order to explore whether
individuals with restrictive EDs under-report illness se-
verity and impairment.
Further studies are needed to examine possible predic-
tors of QoL and impairment in EDs. It seems likely that
the relationships between clinical variables and impair-
ment may be complex. For example, any link between
illness duration and impairment is likely to be compli-
cated by factors such as response shift and symptom
fluctuation over time. A longitudinal approach may
therefore be necessary to examine this relationship.
Other variables may influence impairment in an inter-
active way. The particularly high degree of impairment
in the binge-purge AN group, and the correlation with
BMI in this group, suggests that bingeing and/or purging
behaviours and BMI may have interactive or additive
effects on functional impairment. Further work with
large patient groups is needed to explore this possibility.
Implications for clinicians
Clinicians need to be aware of the high level of func-
tional impairment found across the EDs, as this impair-
ment is an important focus for intervention and may
also significantly impact on factors such as readiness
to change and motivation. Across ED diagnoses, CIA
scores were very high compared to reported population
norms [28,36,37], which suggests that individuals with
EDs are severely impaired by their disorder and are very
aware of the impairment they experience as a result oftheir ED. A focus on functional impairment in treatment
may therefore help to increase motivation and readiness
to change by highlighting the benefits of making changes
to current eating behaviours. The CIA seems to be par-
ticularly appropriate for use in clinical work, as it was
developed with input from ED patients [26], and there-
fore measures impairment in domains experienced as
personally relevant to these patients.
Conclusion
Patients with EDs have very poor QoL compared to the
general population, and individuals with EDs charac-
terised by bingeing and/or purging behaviours seem to
be particularly impaired. Impairment also seems to in-
crease with illness severity, but does not appear to be
related to the frequency of bingeing/purging behaviours,
BMI or illness duration. The exception to this pattern is
AN-BP patients, for whom decreased BMI is related
to greater impairment. This suggests that the presence
of bingeing/purging behaviour and low BMI may have
interactive effects on impairment. Further work is
needed to examine the role of various clinical variables
in predicting the level of impairment associated with
EDs and possible interactions between these variables.
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